The MAPK pathway, commonly known as the RAS/RAF/MEK/ERK signal cascade, is the most frequently mutated signaling pathway in lung cancer; targeting the MAPK pathway has long been considered a promising strategy in cancer therapy [27]. Here, MAP2K7 is linked to cancer.